A detailed history of Benedetti & Gucer, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Benedetti & Gucer, Inc. holds 20,719 shares of PFE stock, worth $535,171. This represents 0.29% of its overall portfolio holdings.

Number of Shares
20,719
Previous 22,054 6.05%
Holding current value
$535,171
Previous $634,000 9.31%
% of portfolio
0.29%
Previous 0.34%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$25.89 - $29.73 $34,563 - $39,689
-1,335 Reduced 6.05%
20,719 $575,000
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $11,915 - $15,476
-456 Reduced 2.03%
22,054 $634,000
Q3 2023

Nov 02, 2023

SELL
$32.09 - $37.51 $52,274 - $61,103
-1,629 Reduced 6.75%
22,510 $746,000
Q2 2023

Jul 20, 2023

BUY
$36.12 - $41.79 $217,550 - $251,701
6,023 Added 33.25%
24,139 $886,000
Q1 2023

Apr 26, 2023

BUY
$39.39 - $51.28 $426,751 - $555,567
10,834 Added 148.78%
18,116 $739,000
Q4 2022

Jan 23, 2023

BUY
$41.75 - $54.5 $54,567 - $71,231
1,307 Added 21.87%
7,282 $373,000
Q3 2022

Oct 26, 2022

SELL
$43.76 - $53.42 $8,883 - $10,844
-203 Reduced 3.29%
5,975 $261,000
Q3 2022

Oct 25, 2022

SELL
$43.76 - $53.42 $54,831 - $66,935
-1,253 Reduced 16.86%
6,178 $241,000
Q2 2022

Aug 05, 2022

BUY
$46.53 - $55.17 $27,964 - $33,157
601 Added 8.8%
7,431 $387,000
Q1 2022

Apr 22, 2022

BUY
$45.75 - $56.69 $9,012 - $11,167
197 Added 2.97%
6,830 $353,000
Q4 2021

Jan 20, 2022

SELL
$41.32 - $61.25 $23,015 - $34,116
-557 Reduced 7.75%
6,633 $391,000
Q3 2021

Nov 05, 2021

BUY
$39.25 - $50.42 $39,721 - $51,025
1,012 Added 16.38%
7,190 $309,000
Q2 2021

Aug 06, 2021

SELL
$35.91 - $40.68 $40,326 - $45,683
-1,123 Reduced 15.38%
6,178 $241,000
Q1 2021

Apr 30, 2021

BUY
$33.49 - $37.77 $244,510 - $275,758
7,301 New
7,301 $264,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Benedetti & Gucer, Inc. Portfolio

Follow Benedetti & Gucer, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benedetti & Gucer, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benedetti & Gucer, Inc. with notifications on news.